関根 郁夫(セキネ イクオ)

研究者情報全体を表示

論文
  • Stereotactic radiosurgery for patients with brain metastases
    Sekine Ikuo
    Lancet Oncol/15(7)/pp.e247-e248, 2014-06
    PubMed
  • Chronic obstructive pulmonary disease as a risk factor for lung cancer
    Sekine Ikuo
    World J Clin Oncol/5(4)/pp.660-666, 2014-10
    PubMed
  • Alveolar hemorrhage associated with pemetrexed administration
    Sekine Ikuo
    Intern Med/54(7)/pp.833-836, 2015-04
    PubMed
  • Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer
    Sekine Ikuo
    Invest New Drugs, 2015-05
    PubMed
  • The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer
    Sekine Ikuo
    Oncogene/24(16)/pp.2735-2738, 2005-04
    PubMed
  • Phase 1 clinical trials in oncology
    Sekine Ikuo
    N Engl J Med/352(23)/pp.2451-2453, 2005-06
    PubMed
  • A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with lung cancer
    Sekine Ikuo
    J Thoracic Oncol/1(1)/pp.31-37, 2006-01
  • Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patients
    Sekine Ikuo
    Radiother Oncol, 2006-07
  • Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patients
    Sekine Ikuo
    Radiother Oncol/80(1)/pp.93-97, 2006-07
    PubMed
  • Knowledge of efficacy of treatments in lung cancer is not enough, their clinical effectiveness should also be known
    Sekine Ikuo
    J Thoracic Oncol/1(5)/pp.398-402, 2006-06
    PubMed
  • Common arm analysis: One approach to develop the basis for global standardization in clinical trials of non-small cell lung cancer
    Sekine Ikuo
    Lung Cancer/53(2)/pp.157-164, 2006-06
    PubMed
  • Docetaxel consolidation therapy following cisplatin, vinorelbine, and concurrent thoracic radiotherapy in patients with unresectable stage III non-small cell lung cancer
    Sekine Ikuo
    J Thorac Oncol/1(8)/pp.180-185, 2006-10
    PubMed
  • Phase I Study of Cisplatin Analogue Nedaplatin, Paclitaxel, and Thoracic Radiotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
    Sekine Ikuo
    Jpn J Clin Oncol/37(3)/pp.175-180, 2007-04
  • Genes regulating the sensitivity of solid tumor cell lines to cytotoxic agents: a literature review
    Sekine Ikuo
    Jpn J Clin Oncol/37(5)/pp.329-336, 2007-05
    PubMed
  • Bodyweight change during the first 5 days of chemotherapy as an indicator of cisplatin renal toxicity
    Sekine Ikuo
    Cancer Sci/98(9)/pp.1408-1412, 2007-06
    PubMed
  • Problems with registration-directed clinical trials for lung cancer in Japan
    Sekine Ikuo
    Tohoku J Exp Med/213(1)/pp.17-23, 2007-09
  • Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer
    Sekine Ikuo
    Br J Cancer/98(4)/pp.693-696, 2008-2
    PubMed
  • Local control of regional and metastatic lesions and indication for systemic chemotherapy in patients with non-small-cell lung cancer
    Sekine Ikuo
    Oncologist/13 (Suppl 1)/pp.21-27, 2008-01
    PubMed
  • Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy.
    Sekine Ikuo
    Lung Cancer/65(2)/pp.219-222, 2008-12
    PubMed
  • Emerging ethnic differences in lung cancer therapy
    Sekine Ikuo
    Br J Cancer/99(11)/pp.1757-1762, 2008-04
    PubMed
  • Is there a need to take ethnicity into account when considering lung cancer treatment?
    Sekine Ikuo
    Expert Rev Respir Med/3(1)/pp.1-4, 2009-02
    PubMed
  • Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel
    Sekine Ikuo
    Ann Oncol/20(9)/pp.1483-1488, 2009-03
    PubMed
  • Comparative chemotherapeutic efficacy in non-small cell lung cancer patients with postoperative recurrence and stage IV disease
    Sekine Ikuo
    J Thorac Oncol/4(4)/pp.518-512, 2009-04
    PubMed
  • A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with breast cancer
    Sekine Ikuo
    Int J Clin Oncol/14(2)/pp.112-119, 2009-04
    PubMed
  • Innovator and generic cisplatin formulations: comparison of renal toxicity
    Sekine Ikuo
    Cancer Sci/102(1)/pp.162-165, 2010-11
    PubMed
  • さらに表示...